BiomX Statistics

Total Valuation

BiomX has a market cap or net worth of $8.80 million. The enterprise value is $13.96 million.

Market Cap	8.80M
Enterprise Value	13.96M

Important Dates

The last earnings date was Thursday, November 14, 2024, before market open.

Earnings Date	Nov 14, 2024
Ex-Dividend Date	n/a

Share Statistics

BiomX has 17.90 million shares outstanding. The number of shares has increased by 105.68% in one year.

Current Share Class	17.90M
Shares Outstanding	17.90M
Shares Change (YoY)	+105.68%
Shares Change (QoQ)	+52.44%
Owned by Insiders (%)	3.76%
Owned by Institutions (%)	27.87%
Float	11.41M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	0.43
P/TBV Ratio	2.30
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 3.17, with a Debt / Equity ratio of 0.26.

Current Ratio	3.17
Quick Ratio	2.63
Debt / Equity	0.26
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-13.44

Financial Efficiency

Return on equity (ROE) is -37.81% and return on invested capital (ROIC) is -56.09%.

Return on Equity (ROE)	-37.81%
Return on Assets (ROA)	-43.41%
Return on Capital (ROIC)	-56.09%
Revenue Per Employee	n/a
Profits Per Employee	-$122,606
Employee Count	71
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

In the past 12 months, BiomX has paid $11,000 in taxes.

Income Tax	11,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -86.63% in the last 52 weeks. The beta is 1.32, so BiomX's price volatility has been higher than the market average.

Beta (5Y)	1.32
52-Week Price Change	-86.63%
50-Day Moving Average	0.88
200-Day Moving Average	2.42
Relative Strength Index (RSI)	22.06
Average Volume (20 Days)	159,870

Short Selling Information

The latest short interest is 23,032, so 0.13% of the outstanding shares have been sold short.

Short Interest	23,032
Short Previous Month	37,156
Short % of Shares Out	0.13%
Short % of Float	0.20%
Short Ratio (days to cover)	0.74

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-32.31M
Pretax Income	-37.11M
Net Income	-8.71M
EBITDA	-31.10M
EBIT	-32.31M
Earnings Per Share (EPS)	-$3.69

Full Income Statement

Balance Sheet

The company has $23.54 million in cash and $9.75 million in debt, giving a net cash position of $13.79 million or $0.77 per share.

Cash & Cash Equivalents	23.54M
Total Debt	9.75M
Net Cash	13.79M
Net Cash Per Share	$0.77
Equity (Book Value)	37.90M
Book Value Per Share	1.18
Working Capital	19.37M

Full Balance Sheet

Cash Flow

Operating Cash Flow	n/a
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

BiomX does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-105.68%
Shareholder Yield	-105.68%
Earnings Yield	-95.56%
FCF Yield	n/a

Analyst Forecast

The average price target for BiomX is $22.50, which is 4,475.03% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$22.50
Price Target Difference	4,475.03%
Analyst Consensus	Strong Buy
Analyst Count	2
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	-43.41%

Stock Forecasts

Stock Splits

The last stock split was on August 26, 2024. It was a reverse split with a ratio of 0.1:1.

Last Split Date	Aug 26, 2024
Split Type	Reverse
Split Ratio	0.1:1

Scores

Altman Z-Score	n/a
Piotroski F-Score	1